Return to homepagePandemic Pact

Development of aerosolized encapsulated recombinant ACE2 for treating COVID-19 early symptom patients

  • Funded by Natural Sciences and Engineering Research Council of Canada (NSERC)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $38,000

  • Funder

    Natural Sciences and Engineering Research Council of Canada (NSERC)

  • Principal Investigator

    Anubhav Pratap Singh

  • Research Location

    Canada

  • Lead Research Institution

    British Columbia

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Manufacturing processes and products; Biomedical engineering